Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 119

    Fortis Drops plan to sell stake in RHT Health Trust, RHTTM

    Fortis Drops plan to sell stake in RHT Health Trust, RHTTM

    Farhat Nasim18 Jun 2019 1:57 PM IST
    New Delhi: Country's one of the leading super speciality hospital chain, Fortis Healthcare (FHL) has recently scrapped the plan to sell stakes in RHT...
    Pfizer to buy cancer drug developer Array for 10.64 billion Dollars

    Pfizer to buy cancer drug developer Array for 10.64 billion Dollars

    Medical Dialogues Bureau18 Jun 2019 1:47 PM IST
    Pfizer Inc said on Monday it would acquire Array Biopharma Inc for $10.64 billion in cash, giving it access to the target's approved drugs for skin...
    Caplin Point gets 2 USFDA observations for sterile injectable site in Chennai

    Caplin Point gets 2 USFDA observations for sterile injectable site in Chennai

    Farhat Nasim17 Jun 2019 1:46 PM IST
    The US Food and Drug Administration (USFDA) has completed inspection of Caplin Steriles Ltd's site at Gummidipoondi in Tamil Nadu, between June 6-14,...
    Lupin recalls over 18000 bottles of Cefdinir for Oral Suspension in US

    Lupin recalls over 18000 bottles of Cefdinir for Oral Suspension in US

    Farhat Nasim17 Jun 2019 10:58 AM IST
    Cefdinir is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the...
    Aurobindo Pharma lines up over Rs 1395 crore capex for FY20

    Aurobindo Pharma lines up over Rs 1395 crore capex for FY20

    Farhat Nasim17 Jun 2019 10:00 AM IST
    "Around USD 200 million is what we are targeting (on capex in FY20)...Capex for biosimilar may not be a huge one for FY20. The majority of the CAPEX...
    Drugmakers file lawsuit against Government regulation requiring drug prices in TV ads

    Drugmakers file lawsuit against Government regulation requiring drug prices in TV ads

    Farhat Nasim17 Jun 2019 9:15 AM IST
    Drugmakers have argued against the regulation, saying list prices do not reflect the final price paid by patients as it excludes rebates and discounts...
    Judge approves drugstore operator Brasil Pharmas bankruptcy

    Judge approves drugstore operator Brasil Pharma's bankruptcy

    Medical Dialogues Bureau17 Jun 2019 8:59 AM IST
    Brasil Pharma owns three different drugstore chains: Big Ben, Farmais and Farmacia Sant'anna. Difficulties integrating the chains and a rift among...
    Laurus Labs gets 2 USFDA observations for  its API facilities in Visakhapatnam

    Laurus Labs gets 2 USFDA observations for its API facilities in Visakhapatnam

    Farhat Nasim16 Jun 2019 9:35 AM IST
    "This is a regular surveillance audit by USFDA, and no data integrity issues were observed in the inspection," Laurus Labs added.New Delhi: Drugmaker...
    Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director

    Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director

    Farhat Nasim16 Jun 2019 9:31 AM IST
    Sanjay Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country.New Delhi: Pharma...
    Merck Foundation, First Lady of Guinea enters partnership to build healthcare capacity, break infertility stigma

    Merck Foundation, First Lady of Guinea enters partnership to build healthcare capacity, break infertility stigma

    Medical Dialogues Bureau16 Jun 2019 9:20 AM IST
    Merck Foundation will also continue enrolling doctors from Guinea in their one-year oncology fellowship program as a contribution to improve cancer...
    China province eyeing investment opportunities in Indian medical sector

    China province eyeing investment opportunities in Indian medical sector

    Medical Dialogues Bureau16 Jun 2019 9:15 AM IST
    "There is a great opportunity to work in industries such as medical and IT between India and Yunnan. There are many business councils and associations...
    Counterfeit medicines costing pharmaceutical industry billions each year: Report

    Counterfeit medicines costing pharmaceutical industry billions each year: Report

    Medical Dialogues Bureau16 Jun 2019 9:00 AM IST
    Counterfeit medicines cost the EU pharmaceutical sector more than 10 billion euros ($11.3 bn) each year, the report estimates.Paris: Counterfeit...
    PrevNext

    Popular Stories

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok